The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Arcus Biosciences Inc COM 03969F109 49,147 3,540,850 SH   OTR 1, 2, 3, 6, 7, 8 0 3,540,850 0
Constellation Pharmceticls I COM 210373106 188,885 6,009,702 SH   OTR 3, 4, 5, 6, 7, 8, 9, 10 0 6,009,702 0
Constellation Pharmceticls I COM 210373106 1,310 41,674 SH   OTR 3, 8 0 41,674 0
Gritstone Oncology Inc COM 39868T105 18,059 3,102,934 SH   OTR 1, 2, 3 0 3,102,934 0
NGM Biopharmaceuticals Inc COM 62921N105 198,105 16,066,907 SH   OTR 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 0 16,066,907 0
NGM Biopharmaceuticals Inc COM 62921N105 15,489 1,256,237 SH   OTR 3, 8 0 1,256,237 0
RAPT Therapeutics Inc COM 75382E109 143,087 6,727,151 SH   OTR 1, 2, 3, 6, 7, 8, 9, 10 0 6,727,151 0
RAPT Therapeutics Inc COM 75382E109 1,064 50,000 SH   OTR 3 0 50,000 0
Revolution Medicines Inc COM 76155X100 30,017 1,370,022 SH   OTR 3, 6, 7, 8, 9, 10 0 1,370,022 0
Revolution Medicines Inc COM 76155X100 144,767 6,607,362 SH   OTR 3, 8 0 6,607,362 0